182 related articles for article (PubMed ID: 32662401)
21. Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor.
Alessandri C; Bartosiewicz I; Pendolino M; Mancini R; Colasanti T; Pecani A; Morello F; Mastrangelo A; Sabatinelli D; Riccieri V; Di Franco M; Ceccarelli F; Perricone C; Conti F; Valesini G
Clin Exp Rheumatol; 2015; 33(6):824-30. PubMed ID: 26411477
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
Shi J; Knevel R; Suwannalai P; van der Linden MP; Janssen GM; van Veelen PA; Levarht NE; van der Helm-van Mil AH; Cerami A; Huizinga TW; Toes RE; Trouw LA
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17372-7. PubMed ID: 21987802
[TBL] [Abstract][Full Text] [Related]
23. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
24. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
[TBL] [Abstract][Full Text] [Related]
25. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.
Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC
J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911
[TBL] [Abstract][Full Text] [Related]
26. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.
van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA
Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902
[TBL] [Abstract][Full Text] [Related]
27. Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing
Brevet P; Lattard C; Guillou C; Rottenberg P; Fardellone P; Le-Loët X; Lequerré T; Cosette P; Boyer O; Fréret M; Vittecoq O
Front Immunol; 2021; 12():733511. PubMed ID: 34691039
[TBL] [Abstract][Full Text] [Related]
28. Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis.
Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Hamann D; van Schaardenburg D; Toes RE; Trouw LA
Ann Rheum Dis; 2014 Apr; 73(4):780-3. PubMed ID: 24336334
[TBL] [Abstract][Full Text] [Related]
29. Erosive arthritis autoantibodies in systemic sclerosis.
Riccardi A; Martinroche G; Contin-Bordes C; Avouac J; Gobeaux C; Cauvet A; Guerini H; Truchetet ME; Allanore Y
Semin Arthritis Rheum; 2022 Feb; 52():151947. PubMed ID: 35000789
[TBL] [Abstract][Full Text] [Related]
30. Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals.
Ponchel F; Duquenne L; Xie X; Corscadden D; Shuweihdi F; Mankia K; Trouw LA; Emery P
RMD Open; 2022 Dec; 8(2):. PubMed ID: 36535711
[TBL] [Abstract][Full Text] [Related]
31. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
Humphreys JH; Verheul MK; Barton A; MacGregor AJ; Lunt M; Toes RE; Symmons DP; Trouw LA; Verstappen SM
Ann Rheum Dis; 2016 Jun; 75(6):1139-44. PubMed ID: 26443608
[TBL] [Abstract][Full Text] [Related]
32. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
[TBL] [Abstract][Full Text] [Related]
33. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
[TBL] [Abstract][Full Text] [Related]
34. Autoantibody and metalloproteinase activity in early arthritis.
Ponikowska M; Świerkot J; Nowak B; Korman L; Wiland P
Clin Rheumatol; 2019 Mar; 38(3):827-834. PubMed ID: 30406565
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis.
Lamacchia C; Courvoisier DS; Jarlborg M; Bas S; Roux-Lombard P; Möller B; Ciurea A; Finckh A; Bentow C; Martinez-Prat L; Mahler M; Gabay C; Nissen MJ;
Rheumatology (Oxford); 2021 Oct; 60(10):4598-4608. PubMed ID: 33502443
[TBL] [Abstract][Full Text] [Related]
36. Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.
Sidiras P; Spruyt D; Gangji V; Imbault V; Sokolova T; Durez P; Communi D; Rasschaert J; Badot V
Scand J Rheumatol; 2021 Mar; 50(2):118-123. PubMed ID: 33025839
[No Abstract] [Full Text] [Related]
37. Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies.
Nakabo S; Hashimoto M; Ito S; Furu M; Ito H; Fujii T; Yoshifuji H; Imura Y; Nakashima R; Murakami K; Kuramoto N; Tanaka M; Satoh J; Ishigami A; Morita S; Mimori T; Ohmura K
Rheumatology (Oxford); 2017 Jul; 56(7):1217-1226. PubMed ID: 28398552
[TBL] [Abstract][Full Text] [Related]
38. Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.
Brink M; Verheul MK; Rönnelid J; Berglin E; Holmdahl R; Toes RE; Klareskog L; Trouw LA; Rantapää-Dahlqvist S
Arthritis Res Ther; 2015 Feb; 17(1):25. PubMed ID: 25889922
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
[TBL] [Abstract][Full Text] [Related]
40. Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis.
Verheul MK; Vierboom MPM; 't Hart BA; Toes REM; Trouw LA
Arthritis Res Ther; 2017 Nov; 19(1):246. PubMed ID: 29096669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
